According to auctioneer Silicon Valley Disposition, equipment up for sale includes “high-end and late-model (mostly 2022) R&D instruments” including bioreactors.
“But one thing I will say,” says Dr. David Kaplan, “I don’t think stir tank reactors that have been used in pharma are going to work here. They’re just too expensive.”
UPSIDE Foods has engaged in a fresh round of layoffs in a bid to extend its runway as it expands its facility in Emeryville, California.
Berkeley-based Orbillion reckons it can achieve economic production for cell-cultured Wagyu beef “at around 2,000 liters in scale,” says cofounder and CEO Dr. Patricia Bubner.
Funding for cultivated meat peaked at $989m in 2021, dipped slightly to $807m in 2022, then dropped sharply to just $177m in 2023.
The ‘PROFUSE-B8’ bovine myoblasts—muscle progenitor cells—are spontaneously immortalized without the use of genetic engineering.
Cultivated meat startup GOOD Meat has upped the ante in its increasingly ugly legal dispute with bioreactor specialist ABEC over alleged nonpayment of bills by filing a series of counterclaims.
We’re kidding ourselves if we think we can make the unit economics add up for cultivated meat without deploying ‘much much larger’ bioreactors, says Ark Biotech.
Can cultivated meat make the transition from a loss-making novelty served at a handful of high-end restaurants to a commercially viable alternative to animal agriculture?
UPSIDE Foods aims to break ground on a commercial-scale cultivated meat facility in Glenview, Illinois, later this year that will become operational in 2025.
Eat Just’s GOOD Meat cultivated meat division has been sued by a second engineering firm (CRB) over alleged non-payment of bills.
Eat Just’s GOOD Meat cultivated meat division has not paid its bills on time, according to court filings from bioreactor specialist ABEC, which is suing for breach of contract.
Omeat—which is scaling up a novel approach to cultivated meat production—is selling an affordable and ‘highly effective’ alternative to FBS.
Dutch cultivated meat startup Meatable has raised $35m in a series B round led by Agronomics, taking its total funding to $95m as it gears up to launch in Singapore next year.
Food tech fantasy or the future of meat? We catch up with Dr. Mark Post to discuss progress in cultivated meat,10 years after he unveiled a rather pricey burger at a press conference in London…
Aleph Farms has applied to Swiss regulators for approval to sell cultivated beef in its first European market: Switzerland.
Cultivated meat startup Omeat has emerged from stealth armed with $40m to fund a novel approach to making meat from animal cells.
UPSIDE Foods has edged closer to commercialization in the US after receiving a thumbs up from USDA for its ‘cell-cultivated chicken’ label, seven months after securing a green light from the FDA.
Dutch startup Meatable has slashed production times for cultivated pork from three weeks to eight days in the past year by dramatically speeding up the process by which its stem cells differentiate into fat and muscle, transforming its unit economics.
Alt protein investor Lever VC has released its internal playbook for assessing the scientific progress of early-stage cultivated meat companies to help investors place more informed bets in a “complex and nascent industry” and help avoid a “Theranos-style outcome.”
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first